Steve Elms, Director, 10% Owner at Loxo Oncology, Inc. (LOXO), sold 500,000 shares at $75.00 ($37.5M) on 2017-11-22, disclosed to the SEC on 2017-11-27.
Open-market sale of $37.5M LOXO by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MRKR | BUY | 2024-12-26 | $35K | — | Filing → |
| ADMA | SELL | 2024-03-19 | $5.6M | — | Filing → |
| ADMA | SELL | 2024-03-15 | $10.2M | — | Filing → |